nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglitol—Pneumatosis intestinalis—Vandetanib—thyroid cancer	0.343	0.648	CcSEcCtD
Miglitol—GANAB—larynx—thyroid cancer	0.137	0.308	CbGeAlD
Miglitol—Intestinal perforation—Vandetanib—thyroid cancer	0.0415	0.0785	CcSEcCtD
Miglitol—GANAB—neck—thyroid cancer	0.0363	0.0816	CbGeAlD
Miglitol—AMY2A—saliva-secreting gland—thyroid cancer	0.0358	0.0803	CbGeAlD
Miglitol—GANC—thyroid gland—thyroid cancer	0.0288	0.0647	CbGeAlD
Miglitol—GANAB—saliva-secreting gland—thyroid cancer	0.0283	0.0637	CbGeAlD
Miglitol—Ileus—Vandetanib—thyroid cancer	0.0232	0.0438	CcSEcCtD
Miglitol—GANAB—trachea—thyroid cancer	0.0219	0.0491	CbGeAlD
Miglitol—GAA—saliva-secreting gland—thyroid cancer	0.0195	0.0437	CbGeAlD
Miglitol—AMY2A—head—thyroid cancer	0.0194	0.0435	CbGeAlD
Miglitol—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.0188	0.0356	CcSEcCtD
Miglitol—GANC—lymph node—thyroid cancer	0.0179	0.0402	CbGeAlD
Miglitol—GANAB—thyroid gland—thyroid cancer	0.0173	0.0388	CbGeAlD
Miglitol—GANAB—head—thyroid cancer	0.0153	0.0345	CbGeAlD
Miglitol—GAA—trachea—thyroid cancer	0.015	0.0337	CbGeAlD
Miglitol—MGAM—head—thyroid cancer	0.0121	0.0272	CbGeAlD
Miglitol—GAA—thyroid gland—thyroid cancer	0.0119	0.0267	CbGeAlD
Miglitol—GANAB—lymph node—thyroid cancer	0.0107	0.0241	CbGeAlD
Miglitol—GAA—head—thyroid cancer	0.0105	0.0237	CbGeAlD
Miglitol—GAA—lymph node—thyroid cancer	0.00738	0.0166	CbGeAlD
Miglitol—Ileus—Epirubicin—thyroid cancer	0.00578	0.0109	CcSEcCtD
Miglitol—Ileus—Doxorubicin—thyroid cancer	0.00535	0.0101	CcSEcCtD
Miglitol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00506	0.00956	CcSEcCtD
Miglitol—Constipation—Vandetanib—thyroid cancer	0.00501	0.00947	CcSEcCtD
Miglitol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00479	0.00905	CcSEcCtD
Miglitol—Abdominal pain—Vandetanib—thyroid cancer	0.00463	0.00875	CcSEcCtD
Miglitol—Rectal haemorrhage—Epirubicin—thyroid cancer	0.00453	0.00857	CcSEcCtD
Miglitol—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.00419	0.00793	CcSEcCtD
Miglitol—Diarrhoea—Vandetanib—thyroid cancer	0.00401	0.00758	CcSEcCtD
Miglitol—Rash—Vandetanib—thyroid cancer	0.00369	0.00698	CcSEcCtD
Miglitol—Dermatitis—Vandetanib—thyroid cancer	0.00369	0.00697	CcSEcCtD
Miglitol—Nausea—Vandetanib—thyroid cancer	0.00348	0.00658	CcSEcCtD
Miglitol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00341	0.00645	CcSEcCtD
Miglitol—Constipation—Sorafenib—thyroid cancer	0.00338	0.00639	CcSEcCtD
Miglitol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00323	0.00611	CcSEcCtD
Miglitol—Abdominal pain—Sorafenib—thyroid cancer	0.00312	0.0059	CcSEcCtD
Miglitol—GAA—Notch-mediated HES/HEY network—HIF1A—thyroid cancer	0.0031	0.12	CbGpPWpGaD
Miglitol—Diarrhoea—Sorafenib—thyroid cancer	0.0027	0.00511	CcSEcCtD
Miglitol—Abdominal distension—Epirubicin—thyroid cancer	0.00258	0.00489	CcSEcCtD
Miglitol—Rash—Sorafenib—thyroid cancer	0.00249	0.00471	CcSEcCtD
Miglitol—Dermatitis—Sorafenib—thyroid cancer	0.00249	0.0047	CcSEcCtD
Miglitol—AMY2A—Carbohydrate metabolism—CHST14—thyroid cancer	0.00247	0.0958	CbGpPWpGaD
Miglitol—Abdominal distension—Doxorubicin—thyroid cancer	0.00239	0.00452	CcSEcCtD
Miglitol—Nausea—Sorafenib—thyroid cancer	0.00235	0.00444	CcSEcCtD
Miglitol—MGAM—Carbohydrate metabolism—CHST14—thyroid cancer	0.0021	0.0814	CbGpPWpGaD
Miglitol—Flatulence—Epirubicin—thyroid cancer	0.00176	0.00333	CcSEcCtD
Miglitol—Flatulence—Doxorubicin—thyroid cancer	0.00163	0.00308	CcSEcCtD
Miglitol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00126	0.00238	CcSEcCtD
Miglitol—Constipation—Epirubicin—thyroid cancer	0.00125	0.00236	CcSEcCtD
Miglitol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00119	0.00226	CcSEcCtD
Miglitol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00117	0.0022	CcSEcCtD
Miglitol—Constipation—Doxorubicin—thyroid cancer	0.00116	0.00218	CcSEcCtD
Miglitol—Abdominal pain—Epirubicin—thyroid cancer	0.00115	0.00218	CcSEcCtD
Miglitol—AMY2A—Carbohydrate metabolism—TPR—thyroid cancer	0.00115	0.0443	CbGpPWpGaD
Miglitol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.0011	0.00209	CcSEcCtD
Miglitol—Abdominal pain—Doxorubicin—thyroid cancer	0.00107	0.00202	CcSEcCtD
Miglitol—Diarrhoea—Epirubicin—thyroid cancer	0.000999	0.00189	CcSEcCtD
Miglitol—MGAM—Carbohydrate metabolism—TPR—thyroid cancer	0.000974	0.0377	CbGpPWpGaD
Miglitol—Diarrhoea—Doxorubicin—thyroid cancer	0.000924	0.00175	CcSEcCtD
Miglitol—Rash—Epirubicin—thyroid cancer	0.000921	0.00174	CcSEcCtD
Miglitol—Dermatitis—Epirubicin—thyroid cancer	0.00092	0.00174	CcSEcCtD
Miglitol—Nausea—Epirubicin—thyroid cancer	0.000867	0.00164	CcSEcCtD
Miglitol—Rash—Doxorubicin—thyroid cancer	0.000852	0.00161	CcSEcCtD
Miglitol—Dermatitis—Doxorubicin—thyroid cancer	0.000851	0.00161	CcSEcCtD
Miglitol—Nausea—Doxorubicin—thyroid cancer	0.000802	0.00152	CcSEcCtD
Miglitol—AMY2A—Disease—TRIM24—thyroid cancer	0.000746	0.0289	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—MINPP1—thyroid cancer	0.000734	0.0284	CbGpPWpGaD
Miglitol—AMY2A—Disease—CHST14—thyroid cancer	0.000701	0.0271	CbGpPWpGaD
Miglitol—AMY2A—Disease—TRIM33—thyroid cancer	0.000665	0.0257	CbGpPWpGaD
Miglitol—MGAM—Disease—TRIM24—thyroid cancer	0.000634	0.0245	CbGpPWpGaD
Miglitol—MGAM—Metabolism—MINPP1—thyroid cancer	0.000624	0.0242	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—NDUFA13—thyroid cancer	0.000624	0.0242	CbGpPWpGaD
Miglitol—MGAM—Disease—CHST14—thyroid cancer	0.000596	0.0231	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—CHST14—thyroid cancer	0.000587	0.0227	CbGpPWpGaD
Miglitol—MGAM—Disease—TRIM33—thyroid cancer	0.000565	0.0219	CbGpPWpGaD
Miglitol—MGAM—Metabolism—NDUFA13—thyroid cancer	0.000531	0.0206	CbGpPWpGaD
Miglitol—MGAM—Metabolism—CHST14—thyroid cancer	0.000499	0.0193	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—HPGD—thyroid cancer	0.000473	0.0183	CbGpPWpGaD
Miglitol—AMY2A—Disease—TCF7L1—thyroid cancer	0.000443	0.0172	CbGpPWpGaD
Miglitol—MGAM—Metabolism—HPGD—thyroid cancer	0.000402	0.0156	CbGpPWpGaD
Miglitol—MGAM—Disease—TCF7L1—thyroid cancer	0.000377	0.0146	CbGpPWpGaD
Miglitol—AMY2A—Disease—TPR—thyroid cancer	0.000325	0.0126	CbGpPWpGaD
Miglitol—AMY2A—Disease—PRKAR1A—thyroid cancer	0.000319	0.0124	CbGpPWpGaD
Miglitol—AMY2A—Disease—MEN1—thyroid cancer	0.000305	0.0118	CbGpPWpGaD
Miglitol—MGAM—Disease—TPR—thyroid cancer	0.000276	0.0107	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—TPR—thyroid cancer	0.000272	0.0105	CbGpPWpGaD
Miglitol—MGAM—Disease—PRKAR1A—thyroid cancer	0.000271	0.0105	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—PRKAR1A—thyroid cancer	0.000267	0.0104	CbGpPWpGaD
Miglitol—MGAM—Disease—MEN1—thyroid cancer	0.000259	0.01	CbGpPWpGaD
Miglitol—AMY2A—Disease—CALCA—thyroid cancer	0.000243	0.00941	CbGpPWpGaD
Miglitol—MGAM—Metabolism—TPR—thyroid cancer	0.000231	0.00895	CbGpPWpGaD
Miglitol—MGAM—Metabolism—PRKAR1A—thyroid cancer	0.000227	0.0088	CbGpPWpGaD
Miglitol—AMY2A—Disease—CDK1—thyroid cancer	0.00022	0.00851	CbGpPWpGaD
Miglitol—MGAM—Disease—CALCA—thyroid cancer	0.000207	0.008	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—SLC5A5—thyroid cancer	0.000203	0.00788	CbGpPWpGaD
Miglitol—MGAM—Disease—CDK1—thyroid cancer	0.000187	0.00724	CbGpPWpGaD
Miglitol—AMY2A—Disease—NRG1—thyroid cancer	0.000177	0.00683	CbGpPWpGaD
Miglitol—MGAM—Metabolism—SLC5A5—thyroid cancer	0.000173	0.0067	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—RXRA—thyroid cancer	0.000171	0.00662	CbGpPWpGaD
Miglitol—AMY2A—Disease—TERT—thyroid cancer	0.000159	0.00614	CbGpPWpGaD
Miglitol—AMY2A—Disease—HIF1A—thyroid cancer	0.000152	0.00587	CbGpPWpGaD
Miglitol—MGAM—Disease—NRG1—thyroid cancer	0.00015	0.00581	CbGpPWpGaD
Miglitol—MGAM—Metabolism—RXRA—thyroid cancer	0.000145	0.00563	CbGpPWpGaD
Miglitol—MGAM—Disease—TERT—thyroid cancer	0.000135	0.00522	CbGpPWpGaD
Miglitol—MGAM—Disease—HIF1A—thyroid cancer	0.000129	0.00499	CbGpPWpGaD
Miglitol—AMY2A—Disease—BRAF—thyroid cancer	0.000126	0.00486	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—PPARG—thyroid cancer	0.000108	0.00418	CbGpPWpGaD
Miglitol—MGAM—Disease—BRAF—thyroid cancer	0.000107	0.00413	CbGpPWpGaD
Miglitol—AMY2A—Disease—PTGS2—thyroid cancer	0.000101	0.00393	CbGpPWpGaD
Miglitol—MGAM—Metabolism—PPARG—thyroid cancer	9.18e-05	0.00355	CbGpPWpGaD
Miglitol—AMY2A—Disease—PTEN—thyroid cancer	8.84e-05	0.00342	CbGpPWpGaD
Miglitol—MGAM—Disease—PTGS2—thyroid cancer	8.62e-05	0.00334	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—PTGS2—thyroid cancer	8.49e-05	0.00329	CbGpPWpGaD
Miglitol—AMY2A—Disease—NRAS—thyroid cancer	7.89e-05	0.00305	CbGpPWpGaD
Miglitol—MGAM—Disease—PTEN—thyroid cancer	7.52e-05	0.00291	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—PTEN—thyroid cancer	7.41e-05	0.00287	CbGpPWpGaD
Miglitol—MGAM—Metabolism—PTGS2—thyroid cancer	7.22e-05	0.00279	CbGpPWpGaD
Miglitol—AMY2A—Disease—KRAS—thyroid cancer	6.79e-05	0.00263	CbGpPWpGaD
Miglitol—MGAM—Disease—NRAS—thyroid cancer	6.71e-05	0.0026	CbGpPWpGaD
Miglitol—MGAM—Metabolism—PTEN—thyroid cancer	6.3e-05	0.00244	CbGpPWpGaD
Miglitol—MGAM—Disease—KRAS—thyroid cancer	5.77e-05	0.00223	CbGpPWpGaD
Miglitol—AMY2A—Disease—HRAS—thyroid cancer	5.77e-05	0.00223	CbGpPWpGaD
Miglitol—AMY2A—Disease—AKT1—thyroid cancer	5.1e-05	0.00197	CbGpPWpGaD
Miglitol—MGAM—Disease—HRAS—thyroid cancer	4.91e-05	0.0019	CbGpPWpGaD
Miglitol—MGAM—Disease—AKT1—thyroid cancer	4.33e-05	0.00168	CbGpPWpGaD
Miglitol—AMY2A—Metabolism—AKT1—thyroid cancer	4.27e-05	0.00165	CbGpPWpGaD
Miglitol—MGAM—Metabolism—AKT1—thyroid cancer	3.63e-05	0.0014	CbGpPWpGaD
